Key result
Ultrasound Abdominal Fat Index distinguishes obese from overweight patients and shows good accuracy for fatty liver.
Why the study?
Intra-abdominal obesity contributes significantly to metabolic dysfunction and hepatic steatosis, prompting evaluation of the ultrasound-derived Abdominal Fat Index as a simple, non-invasive marker to detect obesity, fatty liver, and associated metabolic comorbidities.
Does ultrasound-derived Abdominal Fat Index (AFI) accurately detect obesity, fatty liver, and metabolic comorbidities in adults undergoing abdominal ultrasonography?
Does ultrasound-derived Abdominal Fat Index (AFI) accurately detect obesity, fatty liver, and metabolic comorbidities in adults undergoing abdominal ultrasonography?
Ultrasound-derived Abdominal Fat Index is a reliable, non-invasive marker that correlates with obesity and fatty liver severity, offering a potential screening tool for metabolic risk.
May support AFI as adjunct for metabolic risk stratification on ultrasound; extends cross-sectional data but should not yet change practice.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
International Journal of Medical Science and Innovative Research (IJMSIR) (2025) studied this question. The Ultrasound Abdominal Fat Index (AFI) distinguished obese from overweight patients with significant increases (1.03 vs 0.98, p < 0.001) and showed good diagnostic accuracy for fatty liver (AUC 0.72.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: